Optimizing heart failure treatment in women
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if a personalized medication plan can improve health in women hospitalized with heart failure. It aims to find the best treatment combinations for better recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 85 years old.
- You were hospitalized for heart failure in the last 72 hours with shortness of breath and fluid buildup in the lungs.
- Your blood pressure is at least 100 mmHg and your heart rate is at least 60 beats per minute.
- Your potassium level is 5.0 or lower, and your NT-proBNP level is above a certain threshold (higher if you have atrial fibrillation).
- If your heart pumps less than 50% of blood, you are not on full doses of certain heart medications. If your heart pumps at least 50%, you are not on full doses of a specific medication or SGLT2 inhibitor.
- You are willing to sign a consent form and can follow the study requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This trial uses a national heart failure registry to see if a new way of monitoring treatment can help optimize therapy for people with heart failure and reduced ejection fraction (a weak heart pump). It may lead to better medication adjustments over time.
This study tests whether patients whose heart failure has improved can safely reduce some of their medications. If your heart function has recovered significantly and stayed stable, this trial explores whether you can gradually lower doses of heart failure drugs while staying healthy.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests whether it is safe and effective to increase heart failure medications (like ACE inhibitors, ARBs, ARNIs, MRAs, or SGLT-2 inhibitors) without frequent kidney monitoring. It is for people with heart failure and reduced ejection fraction who are not yet on full doses of these medicines.
This study tests whether a heart-related device called CCM can improve symptoms and daily function in people with heart failure and a moderately reduced pumping strength. It may help if you’ve had recent heart-failure-related hospital care or urgent treatment and your heart and overall health fit the study limits.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.